Adagio Medical grants 30,000 stock options
Adagio Medical Holdings, Inc. reported that director Keyvan Mirsaeedi-Farahani received a grant of 30,000 non-qualified stock options on June 16, 2026.
Rhea-AI Filing Summary
Adagio Medical Holdings, Inc. reported that director Keyvan Mirsaeedi-Farahani received a grant of 30,000 non-qualified stock options on June 16, 2026. The options have an exercise price of $0.7103 per share and expire on June 16, 2036. They were granted under the company’s Non-Employee Director Compensation Policy and 2024 Equity Incentive Plan and will vest in 12 equal monthly installments over one year starting from the vesting commencement date of June 16, 2026. After this grant, the reporting person holds 30,000 options directly.
Insider Trade Summary
Grant/Award: 30,000 shares
Grant/Award
1 txn
Insider
Mirsaeedi-Farahani Keyvan
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-qualified stock option (right to buy) F1 | 30,000 | $0.00 | $0.00 |
Holdings After Transaction:
Non-qualified stock option (right to buy) — 30,000 contracts (Direct)
Footnotes (1)
- F1. Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.
Key Figures
Options Granted: 30,000 options
Exercise Price: $0.7103 per share
Expiration Date: June 16, 2036
+2 more
5 metrics
Options Granted
30,000 options
Non-qualified stock option grant to director on June 16, 2026
Exercise Price
$0.7103 per share
Conversion or exercise price of the stock options
Expiration Date
June 16, 2036
Expiration of the non-qualified stock option grant
Post-grant Holdings
30,000 options
Total options held directly by the reporting person after the grant
Vesting Schedule
1/12 monthly over one year
Monthly vesting after June 16, 2026 vesting commencement date
Key Terms
Non-qualified stock option, Equity Incentive Plan, Non-Employee Director Compensation Policy, vesting commencement date
4 terms
Non-qualified stock option financial
"Non-qualified stock option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Equity Incentive Plan financial
"under the Issuer's ... 2024 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Non-Employee Director Compensation Policy financial
"under the Issuer's Non-Employee Director Compensation Policy"
vesting commencement date financial
"after the vesting commencement date of 06/16/2026"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Adagio Medical Holdings (ADGM) report in this Form 4 for Keyvan Mirsaeedi-Farahani?
Adagio Medical Holdings reported that director Keyvan Mirsaeedi-Farahani received a grant of 30,000 non-qualified stock options on June 16, 2026. These options are part of director compensation and were awarded at an exercise price of $0.7103 per share.
What are the key terms of the 30,000 stock options granted by ADGM?
The grant consists of 30,000 non-qualified stock options with an exercise price of $0.7103 per share and an expiration date of June 16, 2036. The options relate to the company’s common stock and are held directly by the reporting person.
How do the ADGM stock options granted to Mirsaeedi-Farahani vest?
The options will vest in 12 equal monthly installments over a one-year period. Specifically, 1/12 of the shares underlying the option vests at the end of each month of continuous service after the vesting commencement date of June 16, 2026.
Under which plans were the ADGM options to Mirsaeedi-Farahani granted?
The 30,000 options were granted under Adagio Medical Holdings’ Non-Employee Director Compensation Policy and its 2024 Equity Incentive Plan. These frameworks govern equity-based compensation for non-employee directors of the company.
What is Mirsaeedi-Farahani’s reported holdings after this ADGM option grant?
Following the reported grant, the filing states that Mirsaeedi-Farahani holds 30,000 stock options directly. These options are all tied to the June 16, 2026 grant and are subject to the specified vesting schedule and June 16, 2036 expiration date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
